|Last Price$50.40||Day Change (%)1.90%|
|Open Price$49.75||Day Change ($)0.94|
|Day Range49.30–50.43||52-Week Range48.83–80.84|
As of Fri 2/12/2016 5:33:00 PM | USD
FDA Classifies St . Jude Medical Field Action for 447 of the Company's Optisure High Voltage Leads as a Class 1 Advisory in the U.S.
Global Neurostimulation Devices Market Growth of 12.7% CAGR by 2020 - Analysis, Technologies & Forecast Report - Key Vendors: Boston Scientific Corporation, Cochlear Ltd & St Jude Medical Inc - Research and Markets
St . Jude Medical Offers Weak Profit Outlook
Global Optical Imaging Market - Projected to Reach $1.75 Billion by 2020 - Research and Markets
Global 3D Mapping and Modeling Market Growth at 8.54% Between 2016-2020 - 3D Mapping Gaining Popularity in Healthcare Sector - Research and Markets
Global Outsourced Orthopedic Manufacturing Market to Exceed USD 2 Billion by 2020, According to Technavio
St Jude Lead Recall Gets Most Severe Designation By FDA
Global Ultrasound Market Report 2016-2021 - Market is Dominated by GE, Siemens & Philips - Research and Markets
New Activist Hedge Fund by Ex-J.P. Morgan Deal Makers Makes First Investment
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.